The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of nivolumab in patients with advanced refractory biliary tract cancers (BTC).
 
Richard D. Kim
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech; Lilly
Speakers' Bureau - Lilly; Taiho Pharmaceutical
Research Funding - Bayer; Eisai; Novartis
 
Dae Won Kim
No Relationships to Disclose
 
Olatunji B. Alese
Consulting or Advisory Role - AstraZeneca; Conjupro Biotherapeutics; Exelixis; Purdue Pharma
Research Funding - Acetylon Pharmaceuticals (Inst); Bristol-Myers Squibb (Inst); Five Prime Therapeutics (Inst); Ipsen (Inst); Taiho Pharmaceutical (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Exelixis
 
Daneng Li
Consulting or Advisory Role - Bayer; Exelixis; Ipsen; Lexicon; Novartis
Speakers' Bureau - Advanced Accelerator Applications; Exelixis; Ipsen; Lexicon
 
Neal Shah
No Relationships to Disclose
 
Michael J. Schell
No Relationships to Disclose
 
Jun Min Zhou
No Relationships to Disclose
 
Vincent Chung
Consulting or Advisory Role - Celgene; Five Prime Therapeutics; Ipsen; Perthera
Speakers' Bureau - AstraZeneca; Celgene; Ipsen